Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: BIOLEGEND, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-09-20 to 2023-12-29
Current total value of award: $24976
Description: BRILLIANT VIOLET 650TM ANTI-HUMAN CD197